IFNα2b stimulated release of IFNγ differentially regulates T cell and NK cell mediated tumor cell cytotoxicity

Immunology Letters

Volumn 108, Issue 1, 2007, Pages 68-77

  Bose, Anamika ^a   Baral, Rathindranath ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Cytotoxicity; Head and neck squamous cell carcinoma; IFN 2b; IFN ; Perforin

Indexed keywords

ALPHA2B INTERFERON; CD56 ANTIGEN; CD8 ANTIGEN; FAS LIGAND; GAMMA INTERFERON; GRANZYME B; PERFORIN; RECOMBINANT ALPHA2B INTERFERON; CD40 ANTIGEN; CD40 LIGAND; GRANZYME; INTERLEUKIN 12; MEMBRANE PROTEIN; PORE FORMING CYTOTOXIC PROTEIN;

ADULT; ARTICLE; CANCER IMMUNOLOGY; CD8+ T LYMPHOCYTE; CELL STRAIN K 562; CELL STRAIN KB; CELL STRAIN MCF 7; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY TEST; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUTH CANCER; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TUMOR CELL DESTRUCTION; APOPTOSIS; BIOSYNTHESIS; BLOOD; CYTOTOXICITY; DRUG EFFECT; HEAD AND NECK TUMOR; IMMUNOLOGY; METABOLISM; MIDDLE AGED; SECRETION; TUMOR CELL LINE;

ADULT; ANTIGENS, CD40; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CD40 LIGAND; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; FEMALE; GRANZYMES; HEAD AND NECK NEOPLASMS; HUMANS; INTERFERON ALFA-2B; INTERFERON TYPE II; INTERLEUKIN-12; KILLER CELLS, NATURAL; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTES;

EID: 33845803078     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2006.10.002     Document Type: Article

References (15)

1. Chen Z., Malhotra P.S., Thomas G.R., Ondrey F.G., Duffey D.C., Smith C.W., et al. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 5 (1999) 1369-1379
2. Bose A., Ghosh D., Pal S., Mukherjee K.K., Biswas J., and Baral R.N. Interferonα2b augments suppressed immune functions in tobacco related head and neck squamous cell carcinoma patients by modulating cytokine signaling. Oral Oncol 42 (2006) 161-171
3. Billiau A, Vandenbrock K. Cytokine reference, vol. 1. Ligands 645-688. New York: Academic Press; 2001.
4. Kagi D., Ledermann E., Burki K., Zinkernagel R.M., and Hengartner. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol 14 (1996) 207-232
5. Boehm U., Klamp T., Groot M., and Howard J.C. Cellular responses to interferon-γ. Annu Rev Immunol 15 (1997) 749-795
6. Baral R.N., and Chattopadhyay U. Neem (Azadirachta indica) leaf mediated immune activation causes prophylactic growth inhibition of murine Ehrlich carcinoma and B16 melanoma. Int Immunopharmacol 4 (2004) 355-366
7. Alzonei M.Z., Fisher R.I., and Ellis T.M. CD30 defines a subset of activated human T cell that produce IFNγ and IL-5 and exhibit enhanced B cell helper activity. J Immunol 153 (1994) 2861-2867
8. Nansen A.T., Jensen J.P., Cristiansen, Ropke S.O., Marker O., and Thomson A.R. Compromised viral controland augmented perforin mediated immunopathology in IFNγ-deficient mice infected with lymphochoriomeningitis virus. J Immunol 163 (1999) 6114-6122
9. + T cells. Nature 401 (1999) 76-79
10. Vandenbroek M.E., Kagi D., Ossendorp F., Toes S., Vamvakas W.K., Lutz C.J., et al. Decreased after surveillance in perforin deficient mice. J Exp Med 184 (1996) 1781-1790
11. Smyth M.J., Kally J.M., Baxter A.G., Korner H., and Sedgwick J.D. An essential role for tumor necrosis factor in natural killer cell mediated tumor rejection in the peritoneum. J Exp Med 188 (1998) 1611-1619
12. Smyth M.J., Thia K.Y., Cretney E., Kelly J.M., Snook M.B., Forbes C.A., et al. Perforin is a major contributor to NK cell control of tumor metastasis. J Immunol 162 (1999) 6658-6662
13. Shayana E.A., Cretney E., and Smyth M.J. Perforin and interferon-γ activities independently control tumor initiation, growth and metastasis. Blood 97 (2001) 192-197
14. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., et al. Inhibition of death receptor signals by cellular FLIP. Nature 388 (1997) 190-195
15. Tschopp J., Irmler M., and Thome M. Inhibition of Fas death signals by FLIPs. Curr Opin Immunol 10 (1998) 552-558